TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients

On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled ”Thalassaemia/SCD and COVID-19: Possible risks and a proposal for a patient pathway during the pandemic”, which registered more than 700 participants from all over the world!

Experts from Italy & Cyprus, including TIF’s Executive Director Dr Androulla Eleftheriou, Prof. Maria D. Cappellini and others shared with the audience useful insights on the management and outcomes of  thalassaemia and sickle cell disease patients, in the context of the COVID-19 pandemic.

Click on the image below to watch the full webinar:

To access the webinar’s slides, please click here.